/
ATTBF
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
OS
Borrow rate
0.97%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $17.4K | $7.7K | $91.9K | $0 | $0 | $8.4K | $356.9K |
| Cost of revenue | $0 | $11.8K | $0 | $29.3K | $0 | $0 | $1.9K | $115.5K |
| Gross profit | $0 | $5.6K | $7.7K | $62.6K | $0 | $0 | $6.5K | $241.3K |
| Gross margin | — | 32.3% | 100.0% | 68.1% | — | — | 77.4% | 67.6% |
| R&D | $124.3K | $123.6K | $129.1K | $82.8K | $40.0K | $24.7K | $28.9K | $0 |
| Operating income | −$1.0M | −$1.0M | −$7.4M | −$3.1M | −$2.3M | −$6.4M | −$17.4M | −$4.0M |
| EBITDA | −$965.9K | −$1.0M | −$7.3M | −$3.2M | −$2.1M | −$5.3M | −$17.3M | −$2.9M |
| Net income | −$992.4K | −$1.1M | −$7.6M | −$4.5M | −$2.3M | −$7.6M | −$78.0M | −$3.0M |
| Net margin | — | -6318.7% | -98049.4% | -4864.6% | — | — | -931940.1% | -852.4% |
| EPS (diluted) | -0.09 | -0.04 | -0.16 | -0.07 | -0.02 | -0.05 | -0.24 | -0.01 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.00
Price
$0.00
Implied upside
+271086%
Peer comparison
ABATTIS BIOCEUTICALS ORD
ABATTIS BIOCEUTICALS ORD
Held by traders on TradeandTell
No one on the platform currently holds ATTBF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ATTBF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2012-09-11 | 1-for-5reverse |
Recent trades on TradeandTell
No one on the platform has traded ATTBF yet.
